Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: Restoration of Central Vision With PRIMA in Patients With Photoreceptor Degeneration [NA]

View source ↗

Summary

A clinical trial evaluating PRIMA for photoreceptor degeneration is currently recruiting, focusing on Stargardt disease and retinitis pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMA

Snippet

Sponsor: Science Corporation | Conditions: Stargardt Disease, Retinitis Pigmentosa (RP) | NA | Status: RECRUITING